KLK2 and Familial prostate cancer: The 4Kscore uses clinical variables and serum biomarkers (total PSA, free PSA, intact PSA, and human kallikrein 2) to predict the risk of high-grade prostate cancer on biopsy, and categorizes the risk of prostate cancer metastases and mortality.